Tyra Biosciences (TYRA) Earnings Date & Reports

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Companyâ€™s in-house precision medicine platform, SNÃ…P, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TYRA is expected to report earnings to rise 17.07% to -47 cents per share on March 27

Tyra Biosciences TYRA Stock Earnings Reports

Q4'24

Est.

$-0.48

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.11

Q4'23

Missed

by $0.05

The last earnings report on November 07 showed earnings per share of -40 cents, missing the estimate of -40 cents. With 192.13K shares outstanding, the current market capitalization sits at 488.82M.

View a ticker or compare two or three

Compare

TYRA